Medirom Healthcare Technologies Inc. current report, Q1 FY2022

Filing Overview

Medirom Healthcare Technologies Inc. filed a Form 6-K on March 14, 2022, for the month of March 2022. The filing reports the convocation of the company’s 22nd Annual General Meeting of Shareholders for fiscal year 2021.

Business Context and Reporting Period

  • The annual general meeting is scheduled for March 29, 2022, in Tokyo, Japan.
  • The company states that notices, accompanying information, and proxy instructions were sent to holders of its shares and American Depositary Shares.
  • The complete meeting notice is furnished as Exhibit 99.1.

Financial and Operating Information

This filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.

Material Changes Versus Prior Period

The filing does not disclose financial or operating changes versus the prior comparable period. It only reports the meeting notice and related shareholder materials.

Guidance, Outlook, Risks, and Unusual Items

  • No management guidance, outlook, material risks, contingencies, or unusual financial items are disclosed in the filing text.
  • Exhibit 99.1 is identified as the notice of the 22nd Ordinary General Meeting of Shareholders, but its contents are not included in the provided filing text.
  • The exhibit is furnished and is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.

Investor Verification Items

  • Review Exhibit 99.1 for the meeting agenda, proposed resolutions, voting procedures, and shareholder deadlines.
  • Verify the fiscal year 2021 financial results separately, as this Form 6-K does not provide them.
  • Confirm the treatment of American Depositary Shares and applicable proxy or voting instructions.
  • Check the outcome of the March 29, 2022 annual general meeting in subsequent company disclosures.